Scholarlink

Background <p>Early radiation-induced cardiac injury in patients receiving thoracic radiotherapy (RT) remains insufficiently characterized. Global longitudinal strain (GLS) and circulating biomarkers such as high-sensitivity cardiac troponin T (hs-cTnT) and N-terminal pro–B-type natriuretic peptide (NT-proBNP) may detect subclinical myocardialdamage.</p> Methods <p>This prospective single-center cohort study enrolled 47 adults with thoracic malignancies treated with curative-intent RT. Cardiac assessments were performed at baseline, 1 week, and 12 weeks post-RT. GLS was measured by two-dimensional speckle-tracking echocardiography, and hs-cTnT and NT-proBNP were quantified using high-sensitivity immunoassays. Mean heart dose (MHD) was categorized as &lt; 10&#xa0;Gy or ≥ 10&#xa0;Gy to explore dose-stratified differences within this predominantly low-dose exposure cohort. Temporal changes and dose-stratified differences were analyzed using non-parametric tests.</p> Results <p>GLS remained stable across timepoints (median − 18.06% at baseline, − 18.72% at week 1, and − 18.59% at week 12; <i>p</i> = 0.650). Similarly, hs-cTnT showed no significant variation (7.30, 7.50, and 6.60 ng/L, respectively; <i>p</i> = 0.842), and NT-proBNP demonstrated modest, non-significant increases (43.0, 48.5, and 55.5 pg/mL; <i>p</i> = 0.797). Stratification by MHD revealed no significant differences in GLS or biomarker levels at any timepoint. No dose-dependent associations were observed These findings were consistent across subgroups and in sensitivity analyses restricted to completers, in a cohort with a median MHD of 5.1&#xa0;Gy.</p> Conclusions <p>Contemporary thoracic RT was not associated with detectable early subclinical cardiotoxicity within the first 12 weeks under predominantly low cardiac dose exposure. Early cardiac alterations may depend on higher radiation exposure or longer follow-up, supporting longitudinal surveillance strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

No detectable early subclinical cardiotoxicity within 12 weeks of thoracic radiotherapy under predominantly low cardiac dose exposure: a prospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月16日

查看全文
  • Iván Valdés – Orrego,
  • Francisco Acevedo,
  • Tomas Merino

摘要

Background

Early radiation-induced cardiac injury in patients receiving thoracic radiotherapy (RT) remains insufficiently characterized. Global longitudinal strain (GLS) and circulating biomarkers such as high-sensitivity cardiac troponin T (hs-cTnT) and N-terminal pro–B-type natriuretic peptide (NT-proBNP) may detect subclinical myocardialdamage.

Methods

This prospective single-center cohort study enrolled 47 adults with thoracic malignancies treated with curative-intent RT. Cardiac assessments were performed at baseline, 1 week, and 12 weeks post-RT. GLS was measured by two-dimensional speckle-tracking echocardiography, and hs-cTnT and NT-proBNP were quantified using high-sensitivity immunoassays. Mean heart dose (MHD) was categorized as < 10 Gy or ≥ 10 Gy to explore dose-stratified differences within this predominantly low-dose exposure cohort. Temporal changes and dose-stratified differences were analyzed using non-parametric tests.

Results

GLS remained stable across timepoints (median − 18.06% at baseline, − 18.72% at week 1, and − 18.59% at week 12; p = 0.650). Similarly, hs-cTnT showed no significant variation (7.30, 7.50, and 6.60 ng/L, respectively; p = 0.842), and NT-proBNP demonstrated modest, non-significant increases (43.0, 48.5, and 55.5 pg/mL; p = 0.797). Stratification by MHD revealed no significant differences in GLS or biomarker levels at any timepoint. No dose-dependent associations were observed These findings were consistent across subgroups and in sensitivity analyses restricted to completers, in a cohort with a median MHD of 5.1 Gy.

Conclusions

Contemporary thoracic RT was not associated with detectable early subclinical cardiotoxicity within the first 12 weeks under predominantly low cardiac dose exposure. Early cardiac alterations may depend on higher radiation exposure or longer follow-up, supporting longitudinal surveillance strategies.